Respreeza 1,000 mg powder and solvent for solution for infusion., Albumin solution administered intravenously clinical trials

A Phase 2/3, Multicenter, randOmized, Double-blind, placebo-controlled, stUdy to evaLuate the safety and efficacy of Alpha-1 AntiTrypsin for the prEvention of graft versus-host disease in patients receiving hematopoietic cell transplant (MODULAATE Study)

This study looks at a medicine called Alpha-1 AntiTrypsin (Respreeza) to see if it can prevent a serious problem called graft-versus-host disease (GVHD) in people having a stem cell transplant. It will check if the medicine is safe and if it works.